Share this Article
Related Content In Supportive Cancer Care
Cancer Nursing Deserves Better Recognition
European Oncology & Haematology, 2019:15(1):19–20 DOI: https://doi.org/10.17925/EOH.2019.15.1.19
Cancer is a growing problem that demands the best from all sectors of the global health workforce.1 Cancer nurses make up the largest proportion of this workforce and, as well as being responsible for direct care delivery, also aim to address the unmet needs of patients and carers, such as the management of side-effects. Nurses care […]
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
European Oncology & Haematology, 2018;14(1):[Online only]
The authors of the aforementioned article would like to make revisions to the labels in Figure 1 as shown below. The article has been corrected online.
The Impact of Biosimilars in Supportive Care in Cancer
European Oncology & Haematology. 2018;14(1):20–32 DOI: https://doi.org/10.17925/EOH.2018.14.1.20
Biosimilars, which are copies of patent-expired large-molecule biologic drugs (Table 1),1–8 offer the same rationale as generic drugs. They can give patients, hospitals and healthcare systems the opportunity to expand patient access to care and offer potential budget savings to reinvest (Table 2).1,2,9 They are designed to be similar in effectiveness, safety and quality to […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!